NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35808323

about

Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis Stress- and Rho-activated ZO-1-associated nucleic acid binding protein binding to p21 mRNA mediates stabilization, translation, and cell survival NKT cell subsets as key participants in liver physiology and pathology Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis Biliary Mucosal Barrier and Microbiome Targeted therapy for hepatocellular carcinoma: novel agents on the horizon Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer How Inflammation Impinges on NAFLD: A Role for Kupffer Cells Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges Neurotropin suppresses inflammatory cytokine expression and cell death through suppression of NF-κB and JNK in hepatocytes NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis Ionone Derivatives from the Mycelium of Phellinus linteus and the Inhibitory Effect on Activated Rat Hepatic Stellate Cells Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis.Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma.15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.Involvement of DNA damage response pathways in hepatocellular carcinoma.SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.BNIP3L promotes cardiac fibrosis in cardiac fibroblasts through [Ca2+]i-TGF-β-Smad2/3 pathway.Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?NF-κB inhibition alleviates carbon tetrachloride-induced liver fibrosis via suppression of activated hepatic stellate cells.A boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-κB signaling in mice.Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis.Fibrosis-dependent mechanisms of hepatocarcinogenesis Screening for the protective effect target of deproteinized extract of calf blood and its mechanisms in mice with CCl4-induced acute liver injury.Genome-wide RNA-Sequencing analysis identifies a distinct fibrosis gene signature in the conjunctiva after glaucoma surgery Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression.Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.MicroRNAs control hepatocarcinogenesis by regulating hepatocyte nuclear factor 4α-inflammatory signal feedback loops.The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice.Up-regulation of RACK1 by TGF-β1 promotes hepatic fibrosis in mice Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target.Intervention of transforming pulmonary fibrosis with NF-κB p65 antisense oligonucleotide.Preventive effect of halofuginone on concanavalin A-induced liver fibrosis.Spontaneous development of hepatocellular carcinoma with cancer stem cell properties in PR-SET7-deficient livers.

P2860

Q21560965-4D205957-EA3B-4CFF-AB6A-0E3742397363 Q24338583-20611B6E-D398-431F-9486-C10CAD76599A Q26766141-1BDA4E38-13DA-4462-8AB0-6B0854913E92 Q26767372-EB77831F-E1EB-434B-98DD-0F4227B99F9F Q26772317-22265874-5922-4D94-A841-C12F4FEA1A80 Q26774309-47A40E1F-3A2E-468E-B9B7-B61527C2DEBF Q26782887-78DF2380-1D14-45F1-8C14-7713897FF1B4 Q27002288-AD56FB9A-D10B-46D8-98C5-3DF9E7206A10 Q27322930-C3BE8457-70FA-4633-8470-DB81B8554AF6 Q28083001-7B5070BC-3345-42F1-9030-1A54415CBF80 Q28272678-1589D546-24DB-4DC5-B304-0B44D49A8593 Q28542459-D33A4B13-4D21-4AEF-AE6B-23EBB26EB9F3 Q28593092-12522682-15EB-423D-869D-50ABD69F015E Q28833323-238AA1E9-07B4-4FC5-98BE-35D091951D00 Q30697447-A86FBB61-5E6D-4CBA-BA24-84C80A53C392 Q30834745-146C8D4D-72B6-4756-BCA3-9167FE5D954F Q33579972-BB5D2895-DECC-454B-813F-64D4811FE8B3 Q33616812-7709DDFA-614D-47F0-B2F9-A673CAEC8B90 Q33689008-1D3C0C82-3181-4E37-A122-DB8A3005A9DC Q33689496-C175FAB8-DDFF-4B6C-B377-6C2E57A38D67 Q33723810-8F7F012B-CF23-47BB-94D7-C6529F8A8707 Q33731308-288B4AB5-616A-44A4-AADC-A224C644BEEB Q33769605-DDC70CB3-24F7-407D-905B-6703CDDE7031 Q33773913-D39D0717-B739-4C04-8B70-B4B9DCF7E6C5 Q33799384-10747DE1-921B-40AA-85CD-A570EF57889F Q33865082-655276EE-C584-4595-BDC4-A0D1034C6664 Q33897796-6FBDD96E-A0C9-4CC1-AC1C-2409AD1933FE Q33912109-79B77730-C6A7-4209-B827-ADF764B229DD Q34193125-6DC0A841-B460-426B-8EF4-0BA94A0BFC34 Q34294469-A5CB4125-6532-4623-96D3-D1FDEFF14F7F Q34413462-D8B1FD72-B000-49C8-BE2B-0B6CB95F8CD5 Q34415901-A22EF965-EB1C-4F64-B04B-2B2C030C2727 Q34427004-EB3F74E3-4CC6-4310-B4E6-81E4EEAB23AA Q34431414-F74A3B10-95B5-40A9-8228-B324C109D946 Q34653295-EC08C779-E846-4641-B1AC-925F819F91F1 Q34687005-D9F60A8D-5A75-43B8-86BC-CC0C28D8E6EE Q34940989-CD154C75-6FF3-4A0B-A1AE-CF8E734D2E0A Q35017127-6B67AA2F-5132-44BD-A69B-6F5437CC240D Q35072681-ECDA9579-048C-4340-8FE2-4BCC5F4FB5BD Q35090652-A60ED856-1F00-4D0D-8847-3580B21F267E

P2860

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35808323

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

@ast

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

@en

type

label

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

@ast

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

@en

prefLabel

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

@ast

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

@en

P1433

Q35808323-57D8371D-C585-4ED2-B618-54A519181C3D

P1476

Q35808323-647AA7E9-4567-4E4D-B27A-FC32B3D9EA77

P2093

Q35808323-2E4A196A-F9BF-41C2-A0A0-2189F4037C93

Q35808323-ECA54B83-5A9F-4E19-83F8-9BF5DD718B1A

P2860

Q35808323-003ED6A5-FE4B-4C8D-8B88-A39CCFCD34DB

Q35808323-05CF4E22-EE32-4D02-860A-F2B18F96A0E0

Q35808323-08255F02-08DF-4731-9A24-0D87DAB032BB

Q35808323-0882E98B-C1E2-4C87-8C2C-FA1F5BBA0596

Q35808323-0A6ACC53-ADC9-4957-8C8F-49B7659C37A6

Q35808323-0AFB96A7-DD1E-491B-A830-09437546335D

Q35808323-0FB69047-EAFA-4789-85D1-A660102754A2

Q35808323-10F10264-6AA1-418B-B237-63219702EC2F

Q35808323-1199D7BE-E0FC-4633-8F7C-1605A93B6C8F

Q35808323-11C56579-73E4-4366-A35E-1C5A4F8D9E51

P2888

Q35808323-307413D5-A6A7-4DB6-BDFE-FED4CB79FC64

P304

Q35808323-F8F36558-443D-456B-B041-23121CB29D60

P31

Q35808323-35F2E01C-99D6-4C26-B257-769B36AD236D

P356

Q35808323-A10EB635-A11D-446A-B216-906A08C004C1

P407

Q35808323-6929D9E4-BDE6-4B9F-B519-E248A6B73DC8

P433

Q35808323-C3122BE3-700D-40D3-A9D9-FEF31E513255

P478

Q35808323-F7C10353-6C99-47FA-AF5D-13ECB0AE20B7

P577

Q35808323-2795F758-3E1A-4ED3-B4CA-5EB2596D4CD8

P5875

Q35808323-4690C256-3886-4F77-B7BA-8CC19BA7BF01

P698

Q35808323-4F67D091-C117-4D4E-BFF6-1DBD3343886A

P921

Q35808323-1DC5D6A5-EBDB-48A6-9A30-A2A2853361F4

P932

Q35808323-16478E69-FEC4-46E6-9E3D-B76B79A9FF1D

P356

NRGASTRO.2010.213

P1433

Nature Reviews Gastroenterology & Hepatology

P1476

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

@en

P2093

Robert F Schwabe

http://www.w3.org/2001/XMLSchema#string

Tom Luedde

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the receptor component of the IkappaBalpha-ubiquitin ligase

Inhibitor of nuclear factor kB kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-terminal kinase activation induced by arsenic

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a

The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B

A fourth IkappaB protein within the NF-kappaB signaling module

MicroRNA-155 is induced during the macrophage inflammatory response

The role of inflammation in cholestasis: clinical and basic aspects

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

P2888

nrgastro.2010.213

P304

108-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRGASTRO.2010.213

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49809897

http://www.w3.org/2001/XMLSchema#string

P698

21293511

http://www.w3.org/2001/XMLSchema#string

P921

P932

3295539

http://www.w3.org/2001/XMLSchema#string